World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 June 2021
Main ID:  NCT02332317
Date of registration: 30/12/2014
Prospective Registration: No
Primary sponsor: Vejle Hospital
Public title: Early, Integrated, Specialized Palliative Rehabilitation
Scientific title: A Randomized, Controlled Phase III Study of Integrated, Specialized Palliative Rehabilitation for Patients With Newly Diagnosed Non-resectable Cancer.
Date of first enrolment: December 2014
Target sample size: 301
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02332317
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Henrik Jensen, Assoc. prof.
Address: 
Telephone:
Email:
Affiliation:  Vejle Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

Participants must:

- be diagnosed with non-resectable cancer less than 8 weeks before inclusion. For
patients with prostate cancer they must be refered to systemic oncology treatment for
the first time less than 8 weeks before inclusion.

- be fit to receive standard oncology treatment and accepting treatment

- read and understand Danish

- sign informed consent

Exclusion Criteria:

- contact with a specialized palliative unit within the last year before inclusion

- unability to cooperate in the study

- missing informed consent



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Advanced Cancer
Intervention(s)
Behavioral: Palliative rehabilitation
Primary Outcome(s)
Effect of the intervention on "The Primary Problem" chosen by the patient. [Time Frame: 6 and 12 weeks]
Secondary Outcome(s)
Effect of the intervention on worries and symptoms of anxiety and depression [Time Frame: 6 and 12 weeks]
Effect of the intervention on all symptoms and problems present in the EORTC-QLQ-C30 Questionnaire [Time Frame: 6 and 12 weeks]
Economic consequences [Time Frame: 3 months after last data collection]
All cause mortality [Time Frame: 3 months after last data collection]
Secondary ID(s)
Pal-Rehab
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Bispebjerg Hospital
Danish Cancer Society
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history